Foresite Capital Fund IV, L.P. 13D and 13G filings for Arbutus Biopharma Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 10:46 am Sale | 2020-12-31 | 13G | Arbutus Biopharma Corporation ABUS | Foresite Capital Fund IV, L.P. | 0 0.000% | -3,705,128 (Position Closed) | Filing |